Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Luonkos is a Finnish wellness and biotechnology-focused skincare company specializing in microbiome-friendly products. The company utilizes the Re-Connecting Nature™ microbial extract, a scientifically developed forest dust designed to simulate exposure to forest biodiversity and support the human immune system. Their product portfolio includes waterless oil cleansing cakes, serums, and powders that are handcrafted in Naantali, Finland, using plastic-free packaging. By bridging the gap between urban living and natural microbial exposure, Luonkos targets consumers seeking evidence-based solutions for sensitive skin and immune health. The company is a pioneer in the forest-based wellness sector, emphasizing sustainability and circular economy principles in its manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Luonkos.